SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0000950005-96-000791
Filing Date
1996-10-03
Accepted
1996-10-03 00:00:00
Documents
1
Period of Report
1996-10-07
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 DEFIN SCHEDULE 14C DEF 14C 19299
  Complete submission text file 0000950005-96-000791.txt   20645
Mailing Address
Business Address 3832 BAY CENTER PLACE HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-22570 | Film No.: 96638781
SIC: 2833 Medicinal Chemicals & Botanical Products